A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS for children and adults living with Lennox–Gastaut syndrome (LGS).
Pascale V Guillot from University College London, Elizabeth Garrett Anderson Institute for Women’s Health, explains stem cell and gene therapy to treat osteogenesis imperfecta, but is this hype or hope?
Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, explains why drug-candidate ABX464 has the potential to address the urgent need for new, safe short- and long-term effective drugs to treat Inflammatory Bowel Diseases.
Chief Executive of the Huntington’s Disease Association, Cath Stanley, maps out the charities ongoing work to support its community, despite the COVID-19 pandemic.
A non-invasive test for the early detection of oesophageal cancer has been developed by a team of researchers at the Medical Research Council (MRC) Cancer Cell Unit and is now being rolled out across Scotland.
15 new studies, backed by £19.6 million through the National Institute for Health Research, will expand research into diagnosing and treating long COVID.
As your specialist in Acute Care, Draeger Medical UK Ltd is focused on providing protective therapy solutions in the operating room, intensive care unit and neonatal intensive care unit. The aim has always been to improve clinical outcomes and reduce risks in acute care; which has never been truer than in the time of a global pandemic.
